Pentadecapeptide BPC-157 137525-51-0

98% up by HPLC

catégories de produits

Nouveaux produits

Détails du produit

Product Information

Product name	Pentadecapeptide / BPC-157
CAS No.	137525-51-0
Sequence	gly-glu-pro-pro-pro-gly- lys-pro-ala-asp-asp-ala-gly-leu-val
Molecular Formula	C62H98 N16O22
Molecular Weight	1419.54
Quality Standard	98% up by HPLC
Appearance	White lyophilized powder

COA of Pentadecapeptide / BPC-157

ITEM	SPECIFICATIONS	RESULTS
Physical Control
Appearance	White Powder	Conforms
Odor	Characteristic	Conforms
Taste	Characteristic	Conforms
Purity	98%	Conforms
Loss on Drying	≤5.0%	Conforms
Ash	≤5.0%	Conforms
Particle size	95% pass 80 mesh	Conforms
Allergens	None	Conforms
Chemical Control
Heavy metals	NMT 10ppm	Conforms
Arsenic	NMT 2ppm	Conforms
Lead	NMT 2ppm	Conforms
Cadmium	NMT 2ppm	Conforms
Mercury	NMT 2ppm	Conforms
GMO Status	GMO Free	Conforms
Microbiological Control
Total Plate Count	10,000cfu/g Max	Conforms
Yeast & Mold	1,000cfu/g Max	Conforms
E.Coli	Negative	Negative
Salmonella	Negative	Negative
Conclusion: Conforms with standards.

Usage

Function of Pentadecapeptide / BPC-157

BPC 157 has a strong anti- inflammatory activity in both acute and chronic inflammation models. BPC 157 was shown to accelerate wound healing and to have a markedangiogenic effect.The preliminary results in clinical trials suggest that BPC 157 may become an important therapeutic tool for the treatment of inflammatory bowel disease. In addition, it significantly facilitates the healing of bone fracture in rats. BPC 157 exhibits an osteogenic effect significantly improving the healing of segmental bone defect, and accelerates the healing of transected rat achilles tendon and transected rat quadriceps muscle.

Besides, BPC 157 induces f-actin formation in fibroblasts.The western blot analysis also showed that BPC 157 is able to increases the extent of phosphorylation of paxillin and fak proteins without affecting the amounts produced.